Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement (Q77143316)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1998

Language	Label	Description	Also known as
English	Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement	scientific article published on 01 August 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

based on heuristic

inferred from title

author name string

S Rodenhuis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D J Richel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

E van der Wall

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J H Schornagel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J W Baars

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C C Koning

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J L Peterse

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J H Borger

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

W J Nooijen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R Bakx

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

O Dalesio

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

E Rutgers

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

352

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

9127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

515-521

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Women Flock to ABMT for Breast Cancer Without Final Proof

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow autotransplantation for solid tumors--prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer studies in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclavicular biopsy as a guideline for the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of the axillary apex biopsy in clinically operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete axillary lymph node dissection for stage I-II carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the prognostic value of triple node biopsy in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin: an active drug in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy regimens for solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901350-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)01350-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9716055%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77143316&oldid=1725047804"